Extreme levels of HbA1c increase incident ESRD risk in Chinese patients with type 2 diabetes: Competing risk analysis in national cohort of Taiwan diabetes study

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Liao, Li Na ^a   Li, Chia Ing ^b,c   Liu, Chiu Shong ^b,c   Huang, Chiu Ching ^b,c   Lin, Wen Yuan ^b,c   Chian, Jen Huai ^a,b   Lin, Cheng Chieh ^b,c   Li, Tsai Chung ^a,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; CAUSE OF DEATH; CHINESE; CLINICAL EVALUATION; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; POPULATION RISK; RISK ASSESSMENT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; COMPLICATION; DIABETES MELLITUS, TYPE 2; KAPLAN MEIER METHOD; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; TAIWAN;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; TAIWAN;

EID: 84939140433     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130828     Document Type: Article

References (31)

1. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. 2012;59(1 Suppl 1):A7, e1-420. Epub 2011/12/30. doi: 10.1053/j. ajkd.2011.11.015 S0272-6386 (11) 01571-X [pii]. PMID: 22177944.
2. The global dominance of diabetes. Lancet. 2013;382(9906):1680. doi: 10.1016/S0140-6736 (13) 62390-9 PMID: 24267986.
3. Yang WC, Hwang SJ. Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance. Nephrol Dial Transplant. 2008;23(12):3977-82. Epub 2008/07/17. doi: 10.1093/ndt/gfn406 gfn406 [pii]. PMID: 18628366.
4. The Report of National Health Insurance, 2007 [in Chinese]. Bureau of National Health Insurance (BNHI), Department of Health, Republic of China (Taiwan). 2007. Available from: http://www.nhi.gov. tw/Resource/webdata/Attach-8965-2-%E9%87%8D%E5%A4%A7%E5%82%B7%E7%97%85%E9%A0%98%E8%AD%89%E6%95%B8%E8%A1%A818-%E9%99%84%E4%BB%B68.pdf.
5. The Report of National Health Insurance, 2011 [in Chinese]. Bureau of National Health Insurance (BNHI), Department of Health, Republic of China (Taiwan). 2011. Available from: http://www.nhi.gov. tw/webdata/webdata.aspx?menu=17&menu-id=661&WD-ID=685&webdata-id=3627.
6. Standards of medical care in diabetes-2012. Diabetes Care. 2012;35 Suppl 1:S11-63. Epub 2012/01/04. doi: 10.2337/dc12-s011 35/Supplement-1/S11 [pii]. PMID: 22187469.
7. Tu ST, Chang SJ, Chen JF, Tien KJ, Hsiao JY, Chen HC, et al. Prevention of diabetic nephropathy by tight target control in an asian population with type 2 diabetes mellitus: a 4-year prospective analysis. Arch Intern Med. 2010;170(2):155-61. Epub 2010/01/27. doi: 10.1001/archinternmed.2009.471 170/2/155 [pii]. PMID: 20101010.
8. Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010;376(9739):419-30. doi: 10.1016/S0140-6736 (10) 60576-4 PMID: 20594588.
9. Perkovic V, Heerspink HL, Chalmers J, Woodward M, Jun. M, Li Q, et al. Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney international. 2013;83(3):517-23. doi: 10.1038/ki.2012.401 PMID: 23302714.
10. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. The New England journal of medicine. 2009;360(2):129-39. doi: 10.1056/NEJMoa0808431 PMID: 19092145.
11. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837-53. Epub 1998/09/22. S0140673698070196 [pii]. PMID: 9742976.
12. Shurraw S, Hemmelgarn B, Lin M, Majumdar SR, Klarenbach S, Manns B, et al. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med. 2011;171(21):1920-7. doi: 10.1001/archinternmed. 2011.537 PMID: 22123800.
13. Oh SW, Kim YC, Koo HS, Jin DC, Na KY, Chae DW, et al. Glycated haemoglobin and the incidence of end-stage renal disease in diabetics. Nephrol Dial Transplant. 2011;26(7):2238-44. doi: 10.1093/ndt/gfq707 PMID: 21098657.
14. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Annals of internal medicine. 2009;150(9):604-12. PMID: 19414839; PubMed Central PMCID: PMC2763564.
15. Introduction to the National Health Insurance Research Database, Taiwan. National Health Research Institutes (NHRI). Available from: http://w3.nhri.org.tw/nhird//date-01.html.
16. Ministry of Health and Welfare. Available from: http://law.moj.gov. tw/LawClass/LawAll.aspx?PCode= L0060006.
17. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics. 1995;51(2):524-32. PMID: 7662841.
18. Coca SG, Ismail-Beigi F, Haq N, Krumholz HM, Parikh CR. Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes. Arch Intern Med. 2012;172(10):761-9. doi: 10.1001/archinternmed. 2011.2230 PMID: 22636820; PubMed Central PMCID: PMC3688081.
19. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, et al. Effects of intensive glucose lowering in type 2 diabetes. The New England journal of medicine. 2008;358(24):2545-59. doi: 10.1056/NEJMoa0802743 PMID: 18539917.
20. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. The New England journal of medicine. 2008;358(24):2560-72. doi: 10.1056/NEJMoa0802987 PMID: 18539916.
21. Dronavalli S, Duka I, Bakris GL. The pathogenesis of diabetic nephropathy. Nature clinical practice Endocrinology & metabolism. 2008;4(8):444-52. doi: 10.1038/ncpendmet0894 PMID: 18607402.
22. Harris RD, Steffes MW, Bilous RW, Sutherland DE, Mauer SM. Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes. Kidney international. 1991;40(1):107-14. PMID: 1921145.
23. Heilig CW, Concepcion LA, Riser BL, Freytag SO, Zhu M, Cortes P. Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. The Journal of clinical investigation. 1995;96(4):1802-14. doi: 10.1172/JCI118226 PMID: 7560072; PubMed Central PMCID: PMC185817.
24. Mishra R, Emancipator SN, Kern T, Simonson MS. High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells. Kidney international. 2005;67(1):82-93. doi: 10.1111/j.1523-1755. 2005.00058.x PMID: 15610231.
25. Lin CL, Wang JY, Huang YT, Kuo YH, Surendran K, Wang FS. Wnt/beta-catenin signaling modulates survival of high glucose-stressed mesangial cells. Journal of the American Society of Nephrology: JASN. 2006;17(10):2812-20. doi: 10.1681/ASN.2005121355 PMID: 16943306.
26. Friedman EA. Advanced glycation end-products in diabetic nephropathy. Nephrol Dial Transplant. 1999;14 Suppl 3:1-9. PMID: 10382974.
27. Porte D Jr, Schwartz MW. Diabetes complications: why is glucose potentially toxic? Science. 1996;272(5262):699-700. PMID: 8614830.
28. Ceriello A, Novials A, Ortega E, La Sala L, Pujadas G, Testa R, et al. Evidence that hyperglycemia after recovery from hypoglycemia worsens endothelial function and increases oxidative stress and inflammation in healthy control subjects and subjects with type 1 diabetes. Diabetes. 2012;61(11):2993-7. doi: 10.2337/db12-0224 PMID: 22891214; PubMed Central PMCID: PMC3478543.
29. Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. Journal of the American Society of Nephrology: JASN. 2007;18(3):896-903. doi: 10.1681/ASN.2006070772 PMID: 17267743.
30. Cohen RM, Smith EP. Frequency of HbA1c discordance in estimating blood glucose control. Current opinion in clinical nutrition and metabolic care. 2008;11(4):512-7. doi: 10.1097/MCO. 0b013e32830467bd PMID: 18542015.
31. Riveline JP, Teynie J, Belmouaz S, Franc S, Dardari D, Bauwens M, et al. Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system. Nephrol Dial Transplant. 2009;24(9):2866-71. doi: 10.1093/ndt/gfp181 PMID: 19389864.